Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$325K Sell
3,454
-707
-17% -$74.3K 0.13% 165
2023
Q2
$436K Sell
4,161
-151
-4% -$16.1K 0.16% 145
2023
Q1
$476K Buy
4,312
+2,111
+96% +$223K 0.19% 124
2022
Q4
$250K Buy
+2,201
New +$228K 0.13% 144
2021
Q3
Sell
-3,974
Closed -$476K 119
2021
Q2
$476K Buy
3,974
+505
+15% +$58.9K 0.1% 176
2021
Q1
$420K Sell
3,469
-3,958
-53% -$469K 0.12% 160
2020
Q4
$849K Buy
7,427
+504
+7% +$54.8K 0.26% 96
2020
Q3
$746K Buy
+6,923
New +$702K 0.3% 79

Other funds holding ABT

TRUADVICE's ABT Position: Q3 2023 in Review

TRUADVICE reduced its Abbott (ABT) stake by 17% in Q3 2023, selling an estimated $74.3K and leaving 3,454 shares worth $325K. The position accounts for 0.13% of the portfolio, ranked #165.

TRUADVICE first reported a position in ABT in Q3 2020 and has held it in 8 quarters since. The position peaked at $849K in Q4 2020. 2,681 funds tracked by Wall St. Rank hold ABT as of Q3 2023.

  • TRUADVICE held 3,454 shares of Abbott worth $325K as of Q3 2023.
  • TRUADVICE sold 707 Abbott shares in Q3 2023, an estimated $74.3K.
  • Abbott made up 0.13% of TRUADVICE's portfolio in Q3 2023, its #165 holding.
  • TRUADVICE first reported a position in Abbott in Q3 2020 and has held it in 8 quarters since.
  • TRUADVICE's Abbott position peaked at $849K in Q4 2020.
  • 2,681 funds tracked by Wall St. Rank held Abbott as of Q3 2023.

Based on TRUADVICE's 13F filing for Q3 2023, filed 13 Nov 2023.